AI chatbot helps people rewrite their life story for better mental health

NCT ID NCT07494110

Recruiting now Symptom relief Sponsor: Universitat Autonoma de Barcelona Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an AI chatbot called Aurora that guides people through creating a personal life story to improve emotional well-being and identity. It includes healthy adults, adults with mental health conditions in residential care, and older adults aged 65+. The chatbot is not a treatment but a supportive tool to help people express emotions and reflect on their lives.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aurora AI-assisted narrative reconstruction chatbot
What this could lead to: If it works, this could offer a new way to support emotional well-being and personal growth through guided storytelling.
What could go wrong: This is a small, early-stage study with only 55 participants and no control group. The chatbot is not a treatment or diagnostic tool, so benefits may be limited to emotional support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mental disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGING ELDERLY INSTITUTIONALIZATION MENTAL HEALTH WELLBEING

Contacts and locations

Locations

Department of Clinical and Health Psychology; Universitat Autònoma de Barcelona
RECRUITING

Cerdanyola del Vallès, Barcelona, 08193, Spain
Llar Residència Gràcia(Grup ATRA)
NOT_YET_RECRUITING

Barcelona, Barcelona, 08012, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.